Board-level executive with 16 years’ employment at the UK MHRA and, latterly, with accountability for regulatory activities across the UK supply chain, including Inspectorate (all GxPs), enforcement, licensing, clinical trials, pharmacopoeia and premarket medical devices
Expert at crisis management, dealing with national- and international-scale incident management; executive lead for the MHRA’s task force in response to the pandemic
Experience delivering reform and transformational change to highly complex national and globally significant organizations/sectors; recent examples include:
Internationally recognized and networked; previous co-chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) COVID-19 Working Group.
Areas of Expertise: